Schonfeld Strategic Advisors’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-128,360	Closed	-$3.56M	–	2232
2025 Q4	$3.56M	Sell	128,360 -167,730	-57%	-$4.28M	0.02%	670
2025 Q3	$7.19M	Buy	296,090 +67,228	+29%	+$1.34M	0.04%	453
2025 Q2	$3.89M	Buy	+228,862	New	+$3.99M	0.03%	658
2025 Q1	–	Sell	-15,531	Closed	-$385K	–	2207
2024 Q4	$385K	Buy	15,531 +5,514	+55%	+$141K	﹤0.01%	1511
2024 Q3	$245K	Sell	10,017 -20,500	-67%	-$530K	﹤0.01%	1741
2024 Q2	$715K	Sell	30,517 -18,181	-37%	-$447K	﹤0.01%	1347
2024 Q1	$1.61M	Buy	48,698 +23,193	+91%	+$723K	0.01%	1058
2023 Q4	$694K	Sell	25,505 -51,567	-67%	-$1.28M	﹤0.01%	1170
2023 Q3	$1.85M	Buy	77,072 +2,168	+3%	+$58.1K	0.01%	851
2023 Q2	$2.39M	Buy	74,904 +40,839	+120%	+$1.33M	0.02%	695
2023 Q1	$1.04M	Buy	34,065 +13,665	+67%	+$539K	0.01%	943
2022 Q4	$798K	Buy	20,400 +4,869	+31%	+$218K	0.01%	1269
2022 Q3	$739K	Sell	15,531 -42,369	-73%	-$2.42M	0.01%	1480
2022 Q2	$2.24M	Buy	+57,900	New	+$2.3M	0.02%	712
2022 Q1	–	Sell	-12,260	Closed	-$977K	–	2591
2021 Q4	$977K	Buy	12,260 +5,952	+94%	+$510K	0.01%	955
2021 Q3	$549K	Buy	6,308 +4,308	+215%	+$433K	0.01%	1217
2021 Q2	$257K	Buy	+2,000	New	+$159K	﹤0.01%	1542